NIH #5R21CA135604-03
Phase I Study of the BikDD Nanoparticle for Advanced Cancer of the Pancreas
- Amount
- $329K
- Period
- 2009-04-14 → 2013-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Cholangiocarcinoma and Gallbladder Cancer Studies · Surgery
2 total · 0 active
NIH #5R21CA135604-03
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #1R21CA135604-01A1
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
Biomarker study of BND-22 in combination with cemiplimab in solid tumors.
Journal of Clinical Oncology · 2026-05-28
Cancer · 2025-12-19 · 1 citations
npj Systems Biology and Applications · 2025-12-12
2025-12-09
Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach
Clinical Cancer Research · 2025-11-24 · 5 citations
Clinicogenomic Characterization of Primary Sclerosing Cholangitis–Associated Biliary Tract Cancers
Clinical Cancer Research · 2025-11-18 · 2 citations
Clinical Cancer Research · 2025-11-13 · 1 citations
Regular and Young Investigator Award Abstracts · 2025-11-01